Pseudocirrhosis in a pancreatic cancer patient with liver metastases: A case report of complete resolution of pseudocirrhosis with an early recognition and management

World Journal of Gastroenterology

Volumn 14, Issue 10, 2008, Pages 1622-1624

  Kang, Soonmo Peter ^a   Taddei, Tamar ^b   McLennan, Bruce ^b   Lacy, Jill ^a  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy induced liver toxicity; Nodular regenerative hyperplasia; Pancreatic cancer; Pseudocirrhosis

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; CA 19 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GEMCITABINE; HEMOGLOBIN; OXALIPLATIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANKLE EDEMA; ARTICLE; ASCITES; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; DIURESIS; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; DYSPNEA; EARLY INTERVENTION; FEMALE; FLUID RETENTION; HEALTH PRACTITIONER; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER METASTASIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PANCREAS CANCER; PERFORMANCE; PORTAL HYPERTENSION; PROGNOSIS; PSEUDOCIRRHOSIS; QUALITY OF LIFE; RADIOLOGIST; SIDE EFFECT; TREATMENT DURATION; VEIN THROMBOSIS; WEIGHT GAIN;

EID: 41549094516     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1622     Document Type: Article

References (15)

1. Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 1994; 163: 1385-1388
2. Schreiner SA, Gorman B, Stephens DH. Chemotherapy-related hepatotoxicity causing imaging findings resembling cirrhosis. Mayo Clin Proc 1998; 73: 780-783
3. Qayyum A, Lee GK, Yeh BM, Allen JN, Venook AP, Coakley FV. Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver. Clin Imaging 2007; 31: 6-10
4. Sass DA, Clark K, Grzybicki D, Rabinovitz M, Shaw-Stiffel TA. Diffuse desmoplastic metastatic breast cancer simulating cirrhosis with severe portal hypertension: a case of "pseudocirrhosis". Dig Dis Sci 2007; 52: 749-752
5. Fennessy FM, Mortele KJ, Kluckert T, Gogate A, Ondategui-Parra S, Ros P, Silverman SG. Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis. AJR Am J Roentgenol 2004; 182: 651-655
6. Chandrakar V, Isaacs C. Breast cancer-related pseudocirrhosis and esophageal varices. Breast J 2005; 11: 301-302
7. Rosen AA, Iseri O, Fishbein G, Knodell RG. Nodular regenerative hyperplasia: a cause of ascites and hepatomegaly after chemotherapy for leukemia. Am J Gastroenterol 1991; 86: 86-88
8. Key NS, Kelly PM, Emerson PM, Chapman RW, Allan NC, McGee JO. Oesophageal varices associated with busulphanthioguanine combination therapy for chronic myeloid leukaemia. Lancet 1987; 2: 1050-1052
9. Washington K, Lane KL, Meyers WC. Nodular regenerative hyperplasia in partial hepatectomy specimens. Am J Surg Pathol 1993; 17: 1151-1158
10. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15: 460-466
11. Hubert C, Sempoux C, Horsmans Y, Rahier J, Humblet Y, Machiels JP, Ceratti A, Canon JL, Gigot JF. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases? Liver Int 2007; 27: 938-943
12. Coeman DC, Verbeken EK, Nackaerts KL, Demedts MG, Vansteenkiste JF. A fatal case of cholestatic liver failure probably related to gemcitabine. Ann Oncol 2000; 11: 1503
13. Samlowski WE, Gundacker H, Kuebler JP, Giguere JK, Mills GM, Schuller DE, Ensley JF. Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study. Invest New Drugs 2001; 19: 311-315
14. Dobbie M, Hofer S, Oberholzer M, Herrmann R. Veno-occlusive disease of the liver induced by gemcitabine. Ann Oncol 1998; 9: 681
15. Oettle H, Pelzer U, Hochmuth K, Diebold T, Langrehr J, Schmidt CA, Arning M, Vogl TJ, Neuhaus P, Huhn D, Riess H. Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer. Anticancer Drugs 1999; 10: 699-704